Dyadic International's IPO

Dyadic International raised a round of funding on January 10, 2005. Investors include Public.

Dyadic International is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophth…

Articles about Dyadic International's IPO: